Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2021

Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer

Résumé

Liquid biopsies are increasingly used for the diagnosis and follow-up of cancer patients. Urine is a body fluid that can be used to detect cancers and others diseases. It is noninvasive and easy to collect. To detect Bladder Cancer (BC), cytology is the first assay used. It is an effective way to detect high grade BC but has a high rate of equivocal results, especially for low grade BC. Furthermore, cystoscopy is used to confirm cytology results and to determine cancer status. Cystoscopy is also effective but highly invasive, and not well accepted by patients, especially for BC follow-up. In this review we survey the numerous assays recently developed in order to diagnose BC at an early stage, and to facilitate the follow-up of patients. We discuss their effectiveness, ease of use, and applications. Finally, we discuss assays that, in the future, could improve the diagnosis and management of BC patients.

Domaines

Cancer
Fichier principal
Vignette du fichier
cancers-13-01650.pdf (2.24 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03215764 , version 1 (26-05-2021)

Identifiants

Citer

Marine Charpentier, Charly Gutierrez, Thierry Guillaudeux, Gregory Verhoest, Remy Pedeux. Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer. Cancers, 2021, 13 (7), ⟨10.3390/cancers13071650⟩. ⟨hal-03215764⟩
60 Consultations
148 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More